Key result
STOPDAPT-2 investigates clopidogrel versus aspirin beyond one year post-PCI but lacks specific clinical findings.
Final 5-year results compare clopidogrel and aspirin in patients after PCI, indicating significant findings.
URL: https://www.clinicaltrials.gov; Unique identifier: NCT02619760 and NCT03462498.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2026) studied this question. Clopidogrel versus aspirin monotherapy beyond 1 year after PCI was investigated in the STOPDAPT-2 trials, but the provided abstract lacks specific clinical findings or outcome data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: